Clin2
NCT07374198Possibly a fitNot yet recruiting

Esketamine during breast cancer surgery for depression

DepressionAnxietyS-ketamineBreast Cancer

Treatments studied

Part of Cancer, Mental health, Skin clinical trials.

This trial tests whether giving a medication called esketamine during breast cancer surgery can help reduce negative emotions like depression and anxiety after surgery. It is for women who already have mild to severe depression symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
142 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You are scheduled for breast cancer surgery.
  • You have mild to severe depression symptoms.
  • You are not taking certain medications for depression or other mental health conditions.
  • You do not have serious health problems like uncontrolled high blood pressure or heart/liver/kidney issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07374211Not yet recruiting
Esketamine for depression in breast cancer surgery patients

This trial tests whether esketamine, an anesthetic, can help reduce severe depression symptoms in women having breast cancer surgery. You may qualify if you have severe depression before surgery.

NCT07367542Not yet recruiting
Esketamine for emotional well-being during breast cancer surgery

This trial tests whether a medicine called esketamine (given during anesthesia) can help reduce anxiety, sadness, or other negative emotions that often occur before and after breast cancer surgery. This could help you feel better emotionally during your recovery.

Beijing
NCT04303325Recruiting· Phase 4
Esketamine after breast surgery for depression and gut changes

This trial studies whether esketamine given around the time of breast cancer surgery can improve depression and change gut bacteria. It also monitors your sleep/deep anesthesia level (with a simple monitoring number).

Shenyang, Liaoning
NCT06665568Not yet recruiting· Early Phase 1
Ketamine nasal spray for depression and anxiety in cancer

This study tests whether a low dose of ketamine nasal spray can help reduce depression and anxiety in people living with advanced cancer. If you have a progressive cancer and are feeling down or anxious, you might benefit from this quick treatment.

Zurich, Canton of Zurich
NCT06773143Recruiting
Esketamine for sleep quality during breast cancer chemo

This trial tests whether a low dose of esketamine can improve sleep quality in women with breast cancer who are receiving neoadjuvant chemotherapy. If you have trouble sleeping during treatment, this study may find a new way to help.

Nanjing, Jiangsu
NCT07315074Not yet recruiting
Esketamine for better sleep after surgery in postmenopausal women

This trial tests if a low dose of esketamine, given during anesthesia, can improve sleep quality after lower-limb fracture surgery in postmenopausal women. It aims to find a safe way to help you rest better after your operation.

Jingjiang, Jiangsu

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.